TY - JOUR
T1 - Guidelines for the management of dermatomycosis (2019)
AU - Guidelines Committee of the Japanese Dermatological Association
AU - Mochizuki, Takashi
AU - Tsuboi, Ryoji
AU - Iozumi, Ken
AU - Ishizaki, Sumiko
AU - Ushigami, Tsuyoshi
AU - Ogawa, Yumi
AU - Kaneko, Takehiko
AU - Kawai, Masaaki
AU - Kitami, Yuki
AU - Kusuhara, Masahiro
AU - Kono, Takeshi
AU - Sato, Toshiki
AU - Sato, Tomotaka
AU - Shimoyama, Harunari
AU - Takenaka, Motoi
AU - Tanabe, Hiroshi
AU - Tsuji, Gaku
AU - Tsunemi, Yuichiro
AU - Hata, Yasuki
AU - Harada, Kazutoshi
AU - Fukuda, Tomoo
AU - Matsuda, Tetsuo
AU - Maruyama, Ryuji
N1 - Funding Information:
All the costs required for the preparation of the guidelines were paid by the Japanese Dermatological Association. The following declarations are made with regard to the drugs recommended or otherwise mentioned in the guidelines, in accordance with the policy of a 3‐year limitation on conflicts of interest (COI) of the Japanese Dermatological Association: Y. Tsunemi received lecture fees from Eisai, Sato Pharmaceutical and Maruho. K. Harada received lecture fees from Sato Pharmaceutical. R. Maruyama received research funds from Sato Pharmaceutical. R. Tsuboi and K. Harada received a grant from Torii Pharmaceutical, Maruho, Kaken Pharmaceutical and Eisai. Y. Tsunemi received a grant from Maruho. There were no other COI requiring disclosure in the preparation of the present guidelines. If a committee member was involved in the development of a specific drug or its use or had any COI, he or she was strictly excluded from aspects of the work on the present guidelines involving the said drug.
PY - 2020/12
Y1 - 2020/12
N2 - The “Guidelines for the management of dermatomycosis” of the Japanese Dermatological Association were first published in Japanese in 2009 and the Guidelines Committee of the Japanese Dermatological Association revised it in 2019. The first guidelines was prepared according to the opinions of the Guidelines Committee members and it was of educational value. The revised version is composed of introductory descriptions of the disease concepts, diagnosis, medical mycology and recent advances in treatment, along with clinical questions (CQ), which is intended to help in general practice for dermatologists. The CQ are limited to those involved in therapy but include some of the recently launched antifungal agents. The level of evidence and the degree of recommendation for each item were reviewed by the committee based on clinical studies published by 2018. For rare dermatomycoses, recommendations by the committee are described in the guidelines. In this field, there are still few good quality studies on treatment. Periodic revision in line with new evidence is necessary.
AB - The “Guidelines for the management of dermatomycosis” of the Japanese Dermatological Association were first published in Japanese in 2009 and the Guidelines Committee of the Japanese Dermatological Association revised it in 2019. The first guidelines was prepared according to the opinions of the Guidelines Committee members and it was of educational value. The revised version is composed of introductory descriptions of the disease concepts, diagnosis, medical mycology and recent advances in treatment, along with clinical questions (CQ), which is intended to help in general practice for dermatologists. The CQ are limited to those involved in therapy but include some of the recently launched antifungal agents. The level of evidence and the degree of recommendation for each item were reviewed by the committee based on clinical studies published by 2018. For rare dermatomycoses, recommendations by the committee are described in the guidelines. In this field, there are still few good quality studies on treatment. Periodic revision in line with new evidence is necessary.
UR - http://www.scopus.com/inward/record.url?scp=85091861414&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091861414&partnerID=8YFLogxK
U2 - 10.1111/1346-8138.15618
DO - 10.1111/1346-8138.15618
M3 - Article
C2 - 32978814
AN - SCOPUS:85091861414
VL - 47
SP - 1343
EP - 1373
JO - Journal of Dermatology
JF - Journal of Dermatology
SN - 0385-2407
IS - 12
ER -